Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12319745 | Antibodies having specificity for CD38 and uses thereof | Jean-Christophe Bories, Maxime Fayon, Carolina Martinez-Cingolani | 2025-06-03 |
| 11685792 | Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity | Yves Levy, Jean-Francois Eliaou, Nathalie Bonnefoy-Berard | 2023-06-27 |
| 11365392 | Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereof | Daniel Zagury, Helene Le Buanec, Sophie Duchez, Valerie Schiavon | 2022-06-21 |
| 11198851 | Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof | Daniel Zagury, Helene Le Buanec, Sophie Duchez, Valerie Schiavon | 2021-12-14 |
| 11186635 | Monoclonal antibodies binding to the CD160 transmembrane isoform | Bruno Robert, Pierre MARTINEAU, Myriam CHENTOUF, Anne MARIE-CARDINE, Jérôme GIUSTINIANI | 2021-11-30 |
| 10662253 | Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity | Yves Levy, Jean-Francois Eliaou, Nathalie Bonnefoy-Berard | 2020-05-26 |
| 10351623 | Antagonists of IL-17 isoforms and their uses | Gilles Alberici, Jeremy Bastid, Nathalie Bonnefoy, Jean-Francois Eliaou | 2019-07-16 |
| 10208124 | Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis | Philippe Le Bouteiller | 2019-02-19 |
| 9834601 | Antagonists of IL-17 isoforms and their uses | Gilles Alberici, Jeremy Bastid, Nathalie Bonnefoy, Jean-Francois Eliaou | 2017-12-05 |
| 9676847 | IL-17 antagonist antibodies | Gilles Alberici, Jeremy Bastid, Nathalie Bonnefoy, Jean-Francois Eliaou | 2017-06-13 |
| 9045544 | Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis | Philippe Le Bouteiller | 2015-06-02 |
| 8518655 | Means for the diagnosis and therapy of CTCL | Martine Bagot, Laurence Boumsell, Allessandro Moretta | 2013-08-27 |
| 8444978 | Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 | Laurence Boumsell, Phillipe Le Bouteiller | 2013-05-21 |
| 8409573 | Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells | Laurence Boumsell, Jean Kadouche | 2013-04-02 |
| 8268308 | Means for the diagnosis and therapy of CTCL | Martine Bagot, Laurence Boumsell, Allessandro Moretta | 2012-09-18 |
| 8067247 | Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system | Marie-Francoise Belin, Pascale Giraudon, Laurence Boumsell | 2011-11-29 |
| 7919085 | Means for the diagnosis and therapy of CTCL | Martine Bagot, Laurence Boumsell, Allessandro Moretta | 2011-04-05 |
| 7736647 | Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells | Laurence Boumsell, Jean Kadouche | 2010-06-15 |
| 7700102 | Nucleic acids encoding CD100 molecules | Kathryn T. Hall, Gordon J. Freeman, Joachim L. Schultze, Vassiliki Boussiotis, Lee M. Nadler +1 more | 2010-04-20 |
| 7399595 | Means for the diagnosis and therapy of CTCL | Martine Bagot, Laurence Boumsell, Allessandro Moretta | 2008-07-15 |